Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease gastroesophageal reflux disease
Phenotype C0017168|gastroesophageal reflux disease
Sentences 27
PubMedID- 24941823 Objective: to investigate the association between esophageal motility and acid reflux in patients with gastroesophageal reflux disease (gerd).
PubMedID- 20040914 Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease.
PubMedID- 23350046 Transient les relaxation (tlesr) with volume reflux is considered to be a major mechanism of symptomatic gastroesophageal reflux in patients with gastroesophageal reflux disease (gerd).8-10 during volume reflux, the entire surface of the distal esophagus is thought to be exposed to gastric acid.
PubMedID- 24676289 Influence of exercise testing in gastroesophageal reflux in patients with gastroesophageal reflux disease.
PubMedID- 23875101 The aims of this study were to determine whether obesity is associated with gastroesophageal reflux in patients with gastroesophageal reflux disease and to identify the factors affecting increased acid exposure in obese patients.
PubMedID- 23128301 Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy.
PubMedID- 21675271 Aim: to study informative value of 24-h ph monitoring in registration of gastroesophageal and duodenogastroesophageal reflux (ger, dger) in patients with gastroesophageal reflux disease (gerd) before and after surgical treatment.
PubMedID- 21822428 The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease.
PubMedID- 22862140 Small volume acid reflux in gastroesophageal reflux disease patients with hiatal hernia is only detectable by ph-metry but not by multichannel intraluminal impedance.
PubMedID- 23669304 An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.
PubMedID- 20838342 The clinical consequence is rebound acid secretion which may induce dyspeptic symptoms in healthy individuals and exacerbate reflux symptoms in patients with gastroesophageal reflux disease.
PubMedID- 22046769 The pathological gastroesophageal reflux disease may lead to the gastroesophageal reflux disease (gerd), manifested as a spectrum of conditions including erosive esophagitis, barrett esophagus and has been linked to the development of adenocarcinoma of the esophagus.
PubMedID- 25392612 The gastroesophageal reflux disease–health-related quality of life scale (gerd-hrql) was used to assess the severity of reflux.14 the gerd-hrql is a disease-specific, 10-question, 6-point likert-type scale identifying symptoms such as heartburn and bloating.
PubMedID- 25407279 Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study.
PubMedID- 21602991 Nocturnal weakly acidic reflux is as common as acid reflux in patients with gastroesophageal reflux disease, and predominates later in the night.
PubMedID- 25847137 Validated questionnaires such as gastroesophageal reflux disease health-related quality of life (gerd-hrql), reflux symptom index (rsi) and achalasia disease-specific health-related quality of life were obtained pre- and postoperatively.
PubMedID- 22837877 Not all reflux episodes occurring in patients with gastroesophageal reflux disease (gerd) are accompanied by reflux symptoms.
PubMedID- 25587615 Autofluorescence imaging endoscopy for predicting acid reflux in patients with gastroesophageal reflux disease.
PubMedID- 24557959 Conclusion: speed of food intake has no significant impact on acidic reflux attacks in patients with gastroesophageal reflux disease.
PubMedID- 22629750 The article presents research data of duodenogastral reflux (dgr) role in patients with gastroesophageal reflux disease.
PubMedID- 25172606 Gastrointestinal symptoms were evaluated with gastroesophageal reflux disease-health related quality of life (gerd-hrql) questionnaire and gastrointestinal symptom rating scale (gsrs), eating behavior with three-factor eating questionnaire before and one year after rygb.
PubMedID- 25965137 Multiple new endoluminal devices and therapies have been devised to create a more effective antireflux barrier in patients with gastroesophageal reflux disease (gerd).
PubMedID- 25452843 Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease.
PubMedID- 24502186 Introduction: treatment of persistence to proton pump inhibitors or non-acid reflux episodes in patients with gastroesophageal reflux disease is challenging.
PubMedID- 24347282 Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (gerd): a prospective, multicenter, post-marketing observational study.
PubMedID- 26123332 Methods and procedures: data on all patients undergoing poem were collected prospectively between august 2012 and june 2014 and included demographics, objective testing (48-h ph probe, manometry, endoscopy), as well as gastroesophageal reflux disease health-related quality of life (gerd-hrql), gerd symptom scale (gerss), and antacid use.
PubMedID- 24481258 Most physician respondents (79.2%) reported that they would treat chronic hoarseness with reflux medication in a patient without evidence of gastroesophageal reflux disease.

Page: 1